HomeNewsBusinessCompaniesDishman Pharma expects a 15% growth in FY12

Dishman Pharma expects a 15% growth in FY12

In an interview to CNBC-TV18, Dishman Pharma's chief financial officer VVS Murthy said that the change in rupee would not impact the company’s revenues. Murthy projects the company's growth at 15% in FY12.

September 28, 2011 / 10:45 IST
Story continues below Advertisement

In an interview to CNBC-TV18, Dishman Pharma's chief financial officer VVS Murthy said that the change in rupee would not impact the company

first published: Sep 21, 2011 03:13 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!